Neuroimaging of Mouse Models of Alzheimer's Disease

Amandine Jullienne1, Michelle V Trinh1, Andre Obenaus1

  • 1Department of Pediatrics, University of California, Irvine, CA 92697, USA.

Biomedicines
|February 25, 2022
PubMed

Insights

Magnetic resonance imaging (MRI) and positron emission tomography (PET) are crucial for Alzheimer's Disease (AD) research. This review focuses on preclinical neuroimaging in mouse models, enhancing understanding and translation to human AD diagnosis.

Area of Science:

  • Neuroscience
  • Medical Imaging
  • Alzheimer's Disease Research

Background:

  • Alzheimer's Disease (AD) diagnosis and understanding have advanced with human neuroimaging.
  • Mouse models are vital for studying AD's cellular and molecular progression.
  • MRI and PET are increasingly used in mouse models for translational research.

Purpose of the Study:

  • To review human MRI and PET imaging in Alzheimer's Disease.
  • To provide an in-depth overview of preclinical neuroimaging in mouse models of AD.
  • To guide future research in existing and novel AD mouse models.

Main Methods:

  • Comprehensive literature review of published MRI and PET imaging data.
  • Focus on two prominent mouse models: 3xTg-AD and 5xFAD.
  • Analysis of contrasting findings within the selected mouse models.

Main Results:

  • Overview of human MRI and PET imaging landscape for AD.
  • Summary of MRI and PET data in 3xTg-AD and 5xFAD mouse models.
  • Identification of limitations and areas for improvement in preclinical AD imaging.

Conclusions:

  • No single mouse model fully recapitulates the human Alzheimer's Disease spectrum.
  • Preclinical neuroimaging in mice offers a basis for clinical translation.
  • Improvements in MRI and PET imaging are needed for increased rigor and reproducibility in AD research.

Related Concept Videos